Loading...
InnovAge Holding Corp.
INNV•NASDAQ
Healthcare
Medical - Care Facilities
$3.84
$0.04(1.05%)
InnovAge Holding Corp. (INNV) Financial Performance & Income Statement Overview
Review InnovAge Holding Corp.’s income statement, balance sheet, and cash flow reports with annual and quarterly breakdowns.
Revenue Growth
11.01%
↑ 11.01%
Operating Income Growth
53.07%
↑ 53.07%
Net Income Growth
47.54%
↑ 47.54%
Operating Cash Flow Growth
-282.34%
↓ 282.34%
Operating Margin
-3.91%
↓ 3.91%
Gross Margin
17.91%
↑ 17.91%
Net Profit Margin
-3.75%
↓ 3.75%
ROE
-12.10%
↓ 12.10%
ROIC
-10.44%
↓ 10.44%
InnovAge Holding Corp. (INNV) Income Statement & Financial Overview
Review InnovAge Holding Corp.'s (INNV) income statement with detailed quarterly and annual figures.
| Metric | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 |
|---|---|---|---|---|
| Revenue | $209.00M | $205.14M | $199.40M | $193.07M |
| Cost of Revenue | $177.25M | $170.60M | $162.82M | $164.14M |
| Gross Profit | $31.75M | $34.54M | $36.58M | $28.93M |
| Gross Profit Ratio | $0.15 | $0.17 | $0.18 | $0.15 |
| R&D Expenses | $0.00 | $0.00 | $0.00 | $0.00 |
| SG&A Expenses | $35.81M | $34.03M | $36.13M | $33.56M |
| Operating Expenses | $49.62M | $34.03M | $41.46M | $33.56M |
| Total Costs & Expenses | $221.56M | $206.47M | $204.28M | $197.70M |
| Interest Income | $0.00 | $0.00 | $0.00 | $0.00 |
| Interest Expense | $760000.00 | $1.24M | $1.40M | $1.02M |
| Depreciation & Amortization | $5.32M | $5.41M | $5.33M | $5.06M |
| EBITDA | -$7.38M | $1.35M | $5.79M | -$324000.00 |
| EBITDA Ratio | -$0.04 | $0.007 | $0.03 | -$0.002 |
| Operating Income | -$12.56M | -$4.90M | -$4.88M | -$4.63M |
| Operating Income Ratio | -$0.06 | -$0.02 | -$0.02 | -$0.02 |
| Other Income/Expenses (Net) | -$901000.00 | -$410000.00 | $3.94M | -$615000.00 |
| Income Before Tax | -$13.46M | -$5.31M | -$946000.00 | -$6.41M |
| Income Before Tax Ratio | -$0.06 | -$0.03 | -$0.005 | -$0.03 |
| Income Tax Expense | $34000.00 | $404000.00 | $1.31M | -$224000.00 |
| Net Income | -$13.22M | -$4.93M | -$1.70M | -$5.89M |
| Net Income Ratio | -$0.06 | -$0.02 | -$0.009 | -$0.03 |
| EPS | -$0.10 | -$0.04 | -$0.01 | -$0.04 |
| Diluted EPS | -$0.10 | -$0.04 | -$0.01 | -$0.04 |
| Weighted Avg Shares Outstanding | $135.44M | $135.77M | $136.02M | $135.91M |
| Weighted Avg Shares Outstanding (Diluted) | $135.44M | $135.77M | $136.02M | $135.91M |
Unlock 25+ Years of Financial Data
Get access to extended historical data, advanced metrics, and more with our premium plan